AURA
Aura Biosciences Inc
6.20$
-0.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.5% | -5.6% | +2.3% | +0.0% | -7.0% | +0.0% | -1.7% | -2.1% | -2.9% | +0.7% | -5.1% | – | |
| – | +12.0% | +11.8% | +7.5% | -12.0% | +6.8% | +19.6% | +9.1% | -3.8% | -11.0% | +16.5% | +223.4% | – | |
| – | +151.7% | -434.5% | – | +95.8% | -127.9% | – | +379.2% | -3.2% | -20.6% | -127.3% | – | – | |
| – | +252.2% | -72.2% | +496.6% | -35.0% | -12.3% | -37.5% | -79.1% | +15.4% | +291.1% | -42.0% | -79.4% | – | |
| – | -516.7% | – | +111.2% | -50.2% | +200.3% | +0.4% | -33.0% | -320.3% | – | +84.1% | -511.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5,618.6% | -99.7% | -67.2% | +762.7% | -24.2% | -82.3% | +72,742.7% | -93.8% | -36.6% | -89.2% | +153,814.3% | – | |
| – | -284.9% | – | – | -223.0% | – | +3.9% | +958.3% | -186.5% | – | +111.3% | +706.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.